Arizona State Retirement System Has $1.29 Million Holdings in Endo International PLC (NASDAQ:ENDP)

Share on StockTwits

Arizona State Retirement System raised its holdings in Endo International PLC (NASDAQ:ENDP) (TSE:ENL) by 1.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 312,262 shares of the company’s stock after buying an additional 4,167 shares during the quarter. Arizona State Retirement System owned 0.14% of Endo International worth $1,287,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Signition LP acquired a new position in Endo International in the first quarter valued at approximately $139,000. Factorial Partners LLC bought a new stake in shares of Endo International during the first quarter valued at approximately $193,000. First Quadrant L P CA increased its holdings in shares of Endo International by 94.7% during the first quarter. First Quadrant L P CA now owns 24,513 shares of the company’s stock valued at $197,000 after acquiring an additional 11,926 shares in the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of Endo International by 61.4% during the first quarter. Nisa Investment Advisors LLC now owns 42,256 shares of the company’s stock valued at $339,000 after acquiring an additional 16,077 shares in the last quarter. Finally, Piedmont Investment Advisors Inc. increased its holdings in shares of Endo International by 5.8% during the first quarter. Piedmont Investment Advisors Inc. now owns 50,737 shares of the company’s stock valued at $407,000 after acquiring an additional 2,795 shares in the last quarter. 93.37% of the stock is currently owned by hedge funds and other institutional investors.

In related news, Director Roger H. Kimmel sold 34,951 shares of the company’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $3.93, for a total transaction of $137,357.43. Following the completion of the sale, the director now owns 148,309 shares in the company, valued at $582,854.37. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.50% of the company’s stock.

Several equities research analysts have recently commented on the company. ValuEngine downgraded Endo International from a “sell” rating to a “strong sell” rating in a report on Tuesday, May 28th. Morgan Stanley set a $2.00 price objective on Endo International and gave the company a “sell” rating in a report on Friday, August 9th. Canaccord Genuity decreased their price objective on Endo International from $17.00 to $15.00 and set a “buy” rating for the company in a report on Wednesday, May 15th. BidaskClub downgraded Endo International from a “sell” rating to a “strong sell” rating in a report on Thursday, July 18th. Finally, Zacks Investment Research downgraded Endo International from a “buy” rating to a “hold” rating in a report on Wednesday, May 15th. Four research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have given a buy rating to the company’s stock. Endo International has a consensus rating of “Hold” and an average target price of $8.48.

Shares of Endo International stock opened at $2.26 on Monday. The stock has a fifty day simple moving average of $3.39 and a 200 day simple moving average of $6.56. Endo International PLC has a 12-month low of $2.14 and a 12-month high of $18.50. The company has a market capitalization of $504.86 million, a P/E ratio of 0.78 and a beta of 1.14.

Endo International (NASDAQ:ENDP) (TSE:ENL) last announced its quarterly earnings results on Monday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.47 by $0.05. Endo International had a negative return on equity of 129.30% and a negative net margin of 19.98%. The business had revenue of $699.71 million during the quarter, compared to the consensus estimate of $694.60 million. During the same quarter in the prior year, the company posted $0.76 earnings per share. Endo International’s revenue was down 2.1% compared to the same quarter last year. On average, sell-side analysts anticipate that Endo International PLC will post 2.17 EPS for the current fiscal year.

About Endo International

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Read More: The role of implied volatility with call option volume

Institutional Ownership by Quarter for Endo International (NASDAQ:ENDP)

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Swiss National Bank Buys 4,900 Shares of ChannelAdvisor Corp
Swiss National Bank Buys 4,900 Shares of ChannelAdvisor Corp
Doheny Asset Management CA Buys 960 Shares of AT&T Inc.
Doheny Asset Management CA Buys 960 Shares of AT&T Inc.
Doheny Asset Management CA Buys 2,865 Shares of Xilinx, Inc.
Doheny Asset Management CA Buys 2,865 Shares of Xilinx, Inc.
$1.31 EPS Expected for Microchip Technology Inc.  This Quarter
$1.31 EPS Expected for Microchip Technology Inc. This Quarter
Doheny Asset Management CA Has $387,000 Stock Holdings in Lowe’s Companies, Inc.
Doheny Asset Management CA Has $387,000 Stock Holdings in Lowe’s Companies, Inc.
-$0.63 Earnings Per Share Expected for Instructure Inc  This Quarter
-$0.63 Earnings Per Share Expected for Instructure Inc This Quarter


© 2006-2019 Ticker Report